Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print April 10, 2002, 10.1148/radiol.2233011002
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2233011002v1
223/3/702    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cejna, M.
Right arrow Articles by Lammer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cejna, M.
Right arrow Articles by Lammer, J.
(Radiology 2002;223:702-708.)
© RSNA, 2002


Experimental Studies

Inhibition of Neointimal Formation after Stent Placement with Adenovirus-mediated Gene Transfer of I{kappa}B{alpha} in the Hypercholesterolemic Rabbit Model: Initial Results1

Manfred Cejna, MD, Johannes M. Breuss, PhD, Helga Bergmeister, DVM, MD, Rainer de Martin, PhD, Zhongying Xu, MD, Mario Grgurin, MD, Udo Losert, DVM, Hanns Plenk, Jr, MD, Bernd R. Binder, MD and Johannes Lammer, MD

1 From the Departments of Radiology, Division of Angiography and Interventional Radiology (M.C., Z.X., M.G., J.L.) and Vascular Biology and Thrombosis Research (J.M.B., R.d.M., B.R.B.), the Center of Biomedical Research (H.B., U.L.), and Bone and Biomaterials Research, Institute for Histology and Embryology (H.P.), Vienna Medical School, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Received June 6, 2001; revision requested July 20; final revision received November 9; accepted December 11. Supported in part by a Cardiovascular and Interventional Radiological Society of Europe research grant (1999), Mallinckrodt and Schering, and Boston Scientific. Address correspondence to M.C. (e-mail: manfred.cejna@univie.ac.at).

PURPOSE: To evaluate the feasibility and efficacy of the local application of a replication-defective adenovirus construct for the expression of the antiinflammatory protein I{kappa}B{alpha}, inhibitor of nuclear factor {kappa}B (NF-{kappa}B), to reduce neointimal formation after stent placement.

MATERIALS AND METHODS: Nitinol stents were implanted in the iliac arteries of hypercholesterolemic rabbits, followed by balloon dilation (30 seconds at 6 atm). Local adenovirus-mediated transfer of I{kappa}B{alpha} (3 mL of 109 plaque-forming units per milliliter at 6 atm) was performed and compared with three control groups: stent alone, stent plus local delivery of phosphate-buffered saline (PBS) (3 mL at 6 atm), and stent plus local delivery of control adenovirus coding for green fluorescent protein (GFP) (3 mL of 109 plaque-forming units per milliliter at 6 atm). A multichannel balloon was used for local drug delivery and balloon dilation. Animals were sacrificed 1 or 4 weeks after treatment. Effective transfection was demonstrated with immunofluorescence staining. Angiographic patency and luminal diameter were evaluated at quantitative angiography. Luminal and neointimal areas were measured on surface-stained ground sections with methylmethacrylate embedding and the cutting-grinding technique.

RESULTS: All vessels with stents were patent at angiography. Neointimal area was negligible in all groups 1 week after stent placement (range, 0.42–0.52 mm2; P = .44; analysis of variance). Neointimal formation was demonstrated in all groups 4 weeks after implantation but was significantly reduced with I{kappa}B{alpha} treatment compared with treatment with stent alone (by 22%, from 2.80 mm2 ± 0.20 to 2.28 mm2 ± 0.14, P = .05), stent plus PBS (by 43%, from 3.26 mm2 ± 0.25 to 2.28 mm2 ± 0.14, P = .005), and stent plus GFP (by 53%, from 2.32 mm2 ± 0.19 to 1.51 mm2 ± 0.08, P < .005).

CONCLUSION: Local adenovirus-mediated I{kappa}B{alpha} gene transfer has the potential to reduce intimal hyperplasia after stent placement.

© RSNA, 2002

Index terms: Animals • Arteriosclerosis, 9*.7212 • Experimental study • Genes and genetics • Stents and prostheses, 981.1282, 981.1286




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. P. Sorescu, M. Sykes, D. Weiss, M. O. Platt, A. Saha, J. Hwang, N. Boyd, Y. C. Boo, J. D. Vega, W. R. Taylor, et al.
Bone Morphogenic Protein 4 Produced in Endothelial Cells by Oscillatory Shear Stress Stimulates an Inflammatory Response
J. Biol. Chem., August 15, 2003; 278(33): 31128 - 31135.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2002 by the Radiological Society of North America.